CAR-T Mania: Could Juno Therapeutics Get Acquired Next?

CAR-T Mania: Could Juno Therapeutics Get Acquired Next?

Gilead Sciences (NASDAQ: GILD) recently acquired Kite Pharma (NASDAQ: KITE), but that doesn't mean an acquisition of Juno Therapeutics (NASDAQ: JUNO) is off the table. Juno Therapeutics' next-generation CAR-T, JCAR017, could wind up being safer than its competitors' offerings, and if it is, then M&A could be in its future, too.

In this clip from the Motley Fool's Industry Focus: Healthcare podcast, analyst Kristine Harjes and contributor Todd Campbell discuss what's at stake for Juno Therapeutics and its investors.

A full transcript follows the video.

Continue reading

Source: Fool.com